1. 1. Helzlsouer KJ, Alberg AJ, Huang HY, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer . Cancer Epidemiol Biomarkers Prev.1999;8 (6): 525-532 .
2.
2. Zeng T, Holford TR, Mayne ST, et al. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1, 1-dichloro-2,2'-bis(p-chlorophenyl) ethylene . Cancer Epidemiol Biomarkers Prev.2000;9 (2): 167-174 .
3.
3. Archibeque-Engle SL, Tessari JD, Winn DT, et al. Comparison of organochloride pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum . Cancer Epidemiol Biomarkers Prev.1997;52 (4): 285-293 .
4.
4. Aronsen KJ, Miller AB, Woolcott CG, et al. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk . Cancer Epidemiol Biomarkers Prev.2000;9: 55-63 .
5.
5. Charlier C, Albert A, Herman P, et al. Breast cancer and serum organchlorine residues . Occup Environ Med.2003;60 (5): 348-351 .
6.
6. Payne J, Scholze M, Kortenkamp A. Mixtures of four organochlorines enhance human breast cancer cell proliferation . Environ Health Perspect.2001:109 (4): 391-397 .
7.
7. Ardies CM, Dees C. Xenoestrogens significantly enhance risk for breast cancer during growth and adolescence . Med Hypotheses.1998;50 (6): 457-464 .
8.
8. Grover PL, Martin FL. The initiation of breast and prostate cancer . Carcinogenesis.2002;23 (7): 1095-1102 .
9.
9. Galvan-Portillo M, Jimenez-Gutierrez C, Torres-Sanchez L, et al. Food consumption and adipose tissue DDT levels in Mexican women . Cad Saude Publica.2002;18 (2).
10.
10. Dorner G, Plagemann A. DDT in human milk and mental capacities in children at school age: an additional view on PISA 2000 . Neuroendocrinol Lett.2002:23 (5-6): 427-431 .
11.
11. DeBruin LS, Josephy PD. Perspectives on the chemical etiology of breast cancer . Environ Health Perspect.2002;110 (Suppl 1): 119-128 .
12.
12. Imbeault P, Cheurier J, Dewailly E, et al. Increase in plasma pollutant levels in response to weight loss is associated with the reduction of fasting insulin levels in men but not in women . Metabolism.2002;51 (4): 482-486 .
13.
13. Chevrier J, Dewailly E, Ayotte P, et al. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals . Int J Obes Relat Metab Disord.2000;24 (10): 1272-1278 .
14.
14. Imbeault P, Cheverier J, Dewailly E, et al. Increase in plasma pollutant levels in response to weight loss in humans is related to in vitro subcutaneous adipocyte basal lipolysis . Int J Obes Relat Metab Disord.2001;25 (11): 1585-1591 .
15.
15. Martin MB, Reiter R, Phan T, et al. Estrogen-like activity of metals in mcf-7 breast cancer cells . Endocrinology.2003;144 (6): 2425-2435 .
16.
16. Jones JL, Daley BJ. Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrest in T47D breast cancer cells . Am Surg.2002;168 (6): 575-577 .
17.
17. Verma SP, Salamone E, Goldin B. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides . Biochem Biophys Res Commun.1997;233 (3): 692-696 .
18.
18. Harland J, Engstrom S, Liburdy R. Evidence for a slow timescale interaction for magnetic fields inhibiting tamoxifen's antiproliferative action in human breast cancer cells . Cell Biochem Biophys.1999;31 (3): 295-306 .
19.
19. Davis S, Mirick DK, Stevens RG. Night shift work, light at night and risk of breast cancer . J Natl Cancer Inst.2001;93 (20): 1557-1562 .
20.
20. Koo SW, Suh CO, Hann SK, et al. Vitiligo following radiotherapy for carcinoma of the breast . Br J Dermatol.1996;135 (5): 852-853 .
21.
21. Frati R, Frati C, Sassano PP, et al. Vitiligo, autoimmune thyroiditis: a rare thyroid cancer arising with bone metastates on maxillofacial area . J Exp Clin Cancer Res.1999;18 (1): 85-87 .
22.
22. Fenton CL, Patel A, Tattle RM, et al. Autoantibodies to p53 in sera of patients with autoimmune thyroid disease . Ann Clin Lab Sci.2000;30 (2): 179-183 .
23.
23. Lenner P, Wikland F, Emdin SO, et al. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study . Br J Cancer.1999;79 (5-6): 927-932 .
24.
24. Mudenda B, Green JA, Green B, et al. The relationship between serum p53 autoantibodies and characteristics of human breast cancer . Br J Cancer.1994;69 (6): 1115-1119 .
25.
25. Furgerg H, Millkan RC, Geradts J, et al. Environmental factors in relation to breast cancer characterized by p53 protein expression . Cancer Epidemiol Biomarkers Prev.2002;11: 829-835 .
26.
26. Brown SL. Epidemiology of silicone-gel breast implants . Epidemiology.2002;13 (Suppl 3): S34-S39 .
27.
27. Hofseth LJ, Saito S, Hussain SP, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation . Proc Natl Acad Sci U S A.2003;100 (1): 143-148 .
28.
28. Singh B, Lucci A. Rose of cycloxygenase-2 in breast cancer . J Surg Res.2002;109 (1): 173-179 .
29.
29. Koki AT. Characterization of cyclooxygenase-2 (COX-2) March 24-28 expression and Her2/neu in human breast, colon and prostate cancer . Paper presented at: Annual Meeting of the American Association for Cancer Research; 2001; New Orleans, La.
30.
30. Delsite R. Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells . Mol Cancer.2002;1 (6).
31.
31. Kaaks R. Plasma insulin, IGF-I and breast cancer [in French] . Gynecol Obstet Fertil.2001;29 (3): 185-191 .
32.
32. Augustin LS, Dal Maso L, La Vecchia C, et al. Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study . Ann Oncol.2001;12 (11): 1533-1538 .
33.
33. Holmes MD, Pollack MN, Willet WC, et al. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations . Cancer Epidemiol Biomarkers Prev.2002;11: 852-861 .
34.
34. Prosser CG, Fleet IR, Corps AN. Increased secretion of insulin-like growth factor I into milk of cows treated with recombinant derived bovine growth hormone . J Dairy Res.1989;56: 17-26 .
35.
35. Yu H, Berkel H. Insulin-like growth factors and cancer . J La State Med Soc.1999;151 (4): 218-223 .
36.
36. Suga K, Imai K, Eguchi H, et al. Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor 1 receptor and insulin-like growth factor II genes . Jpn J Cancer Res.2001;92: 127-134 .
37.
37. Campbell MJ, Woodside JV, Secker-Walker J, et al. IGF status is altered by tamoxifen in patients with breast cancer . Mol Pathol.2001;54 (5): 307-310 .
38.
38. Fowke JHet al. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women . Cancer Epidemiol Biomarkers Prev.2000;9: 773-779 .
39.
39. Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamins A, C, E and risk of breast cancer . J Natl Cancer Inst.1999;91 (6): 547-556 .
40.
40. Inoue M, Tajima K, Mizutani M, et al. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the hospital-based epidemiologic research program at Aichi cancer center (HERPACC), Japan . Cancer Lett.2001;167 (2): 175-182 .
41.
41. Pianetti St, Guo S, Kavanagh KT, et al. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/Neu signaling, proliferation, and transformed phenotype of breast cancer cells . Cancer Res.2002;62: 652-655 .
42.
42. Wallace J. Nutritional and botanical modulation of the inflammatory cascade-eicosanoids, cyclooxygenases and lipoxygenases as an adjunct in cancer therapy . Int Cancer Ther.2002;1 (1): 7-37 .
43.
43. Board M, Colquhoun A, Newsholme EA. High Km glucose-phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose . Cancer Res.1995:55 (15): 3278-3285 .
44.
44. Dabrosin C, Chen J, Wang L, et al. Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts . Cancer Lett.2002;185 (1): 31-37 .
45.
45. Hutchins AM, Marini MC, Olson BA, et al. Flaxseed consumption influences and endogenous hormone concentrations in postmenopausal women . Nutr Cancer.2001;39 (1): 58-65 .
46.
46. Ando M. Effects of dietary levels of protein and fat on DDT (1,1,1-trichloro-2,2-bis(P-chlorophenyl ethane) and liver lipid metabolism . J Nutr Sci Vitaminol (Tokyo).1982;28(4): 391-400 .
47.
47. Schmitz KH, Ahmed RL, Yee D, et al. Effects of a 9-month training intervention on insulin, insulin-like growth factor (IGF)-1, IGF-binding protein (IGFBP)-1, and IGFBP-3 in 30-50 year old women . Cancer Epidemiol Biomarkers Prev.2002;11: 1597-1604 .
48.
48. Harland JD, Liburdy RP. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in human breast cancer cell line . Bioelectromagnetics.1997;18(8): 555-562 .
49.
49. Cover CM, Hsieh SJ, Cram EJ, et al. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells . Cancer Res.1999;59: 1244-1251 .
50.
50. Portakal O, Ozkaya O, Erden Inal M, et al. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients . Clin Biochem.2000;33(4): 279-284 .